Health - Google News: Pfizer CEO: FDA May Need More Time to Review Tofacitinib Application - Wall Street Journal

Health - Google News Google News

Pfizer CEO: FDA May Need More Time to Review Tofacitinib Application - Wall Street Journal Jul 31st 2012, 14:54 Daily Mail Pfizer CEO: FDA May Need More Time to Review Tofacitinib Application Wall Street Journal By Peter Loftus The US Food and Drug Administration may take longer than expected to review Pfizer Inc.'s (PFE) application to market a new treatment for rheumatoid arthritis, the drug maker's chief said Tuesday. The FDA has requested additional ... Pfizer Rheumatoid Arthritis Drug Beats Older Treatment in StudyBloomberg Pfizer study: Arthritis pill beats standard drugCBS News Can a new Pfizer find success in its long-struggling R&D division?FierceBiotech RTT News -Daily Mail all 52 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: